Get started
Author

Hannes A. Baukmann

Observed name: Hannes Baukmann
ORCID: 0000-0003-3560-6777
Observed ORCID: 0000-0003-3560-6777
OpenAlex ID: A5052247137
Identification of Multiple Druggable Secondary Sites by Fragment Screening against DC‐SIGN
2017 · Jonas Aretz, Hannes Baukmann, et al. · Angewandte Chemie International Edition · 53
Rational Design of a DNA‐Scaffolded High‐Affinity Binder for Langerin
2020 · Gunnar Bachem, Eike‐Christian Wamhoff, et al. · Angewandte Chemie International Edition · 30
PDF
CellFy: A Cell-Based Fragment Screen against C-Type Lectins
2018 · Jessica Schulze, Hannes Baukmann, et al. · ACS Chemical Biology · 27
Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records
2025 · Haraldur Þorsteinsson, Hannes A. Baukmann, et al. · Neuropsychopharmacology · 18
PDF
Identifikation sekundärer Bindestellen auf DC‐SIGN mithilfe eines Fragment‐Screenings
2017 · Jonas Aretz, Hannes Baukmann, et al. · Angewandte Chemie · 11
Interaction-Based Feature Selection Algorithm Outperforms Polygenic Risk Score in Predicting Parkinson’s Disease Status
2021 · Jörn E. Klinger, Charles N. J. Ravarani, et al. · Frontiers in Genetics · 10
PDF
Targeting Longevity Gene SLC13A5: A Novel Approach to Prevent Age-Related Bone Fragility and Osteoporosis
2023 · Grit Zahn, Hannes A. Baukmann, et al. · Metabolites · 9
PDF
Critically ill COVID-19 status associated trait genetics reveals CDK6 inhibitors as potential treatment
2021 · Joern Klinger, Charles Ravarani, et al. · Research Square · 3
PDF
Rational Design of a DNA‐Scaffolded High‐Affinity Binder for Langerin
2020 · Gunnar Bachem, Eike‐Christian Wamhoff, et al. · Angewandte Chemie · 3
PDF
Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment
2021 · Hannes A. Baukmann, Justin L. Cope, et al. · medRxiv · 2
PDF
Retrospective evaluation of human genetic evidence for clinical trial success using Mendelian randomization and machine learning
2026 · Charles N. J. Ravarani, Marius Arend, et al. · medRxiv · 1
PDF
Exploring disease-causing traits for drug repurposing in critically ill COVID-19 patients: A causal inference approach
2023 · Hannes A. Baukmann, Justin L. Cope, et al. · iScience · 1
Mendelian randomization to inform a clinical trial of chitotriosidase inhibition for pulmonary sarcoidosis
2025 · Daniel A. Culver, Marco F. Schmidt, et al. · medRxiv
PDF
High neutrophils and triglycerides lead to critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment
2022 · Marco F. Schmidt, Hannes A. Baukmann, et al. · Research Square
PDF
Corrigendum: Identification of Multiple Druggable Secondary Sites by Fragment Screening against DC‐SIGN
2017 · Jonas Aretz, Hannes Baukmann, et al. · Angewandte Chemie International Edition
PDF
Berichtigung: Identifikation sekundärer Bindestellen auf DC‐SIGN mithilfe eines Fragment‐Screenings
2017 · Jonas Aretz, Hannes Baukmann, et al. · Angewandte Chemie
Works count: 16
Citation count: 168
H-index: 7
I10-index: 6
Year
Topic
Type